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ABSTRACT
Four compounds that belong to two structure types, namely dibenzylbutyrolactone and sesterterpenoids, were obtained from the extract of the strain Aspergillus 
sp. (2P-22), isolated from a marine sponge, Cliona chilensis. Among them, compound 1 was identified as new, namely butylrolactone-VI. The structures of these 
compounds were characterized on the basis of spectroscopic data. Biological activities of these fungal metabolites, are described.
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INTRODUCTION
In the search for novel and bioactive molecules, terrestrial fungi have yielded 
many biologically active compounds. More recently, marine microorganisms 
have gained attention as important sources of chemically interesting and 
biologically active secondary metabolites, due to the diversity in chemical 
structures and biological activities1,2. However, compared with other marine 
organisms, relatively few investigations of the secondary metabolites from 
marine fungi have been reported3. Fungi isolated from various organisms in the 
marine environment, e.g., from mangroves4, algae5, mollusks6 and particularly 
sponges7, have been examined for their secondary metabolite content.
As part of our research on marine fungi, we report here the results regarding 
the secondary metabolite chemistry of 2P-22 strain, Aspergillus sp., isolated 
from the marine sponge Cliona chilensis collected in Los Molles, IV Region, 
Chile. This study led to the isolation of a new compound 1, together with three 
known compounds previously isolated from other fungal sources 8-11 (Figure 1). 
The new compound is structurally related to the known butyrolactone I isolated 
from Aspergillus terreus.12 We described the isolation, structure elucidation, 
and biological activities of these fungal metabolites.
EXPERIMENTAL
General experimental procedures.
1H and 13C-NMR spectra were recorded on a Bruker AMX2-400 
spectrometer, operating at 400.13 for 1H and 100.6 MHz for 13C. Chemical 
shifts are reported in ppm (δ) and coupling constant (J) are given in Hz. The 
spectra were obtained in CDCl3 solutions and are referred to the residual 
peaks of CHCl3 at δ 7.26 ppm and 77.0 ppm for 
1H and 13C respectively. Mass 
spectra were taken at 70 eV (probe) in a Micromass Autospec spectrometer. 
Semipreparative HPLC was carried out with a Beckman System Gold 125P. 
Dry column chromatography was performed on Merck (0.02-0.063 mm) silica 
gel.
Fungal Material. 
The fungi isolate was recovered from the surface of the sponge Cliona 
chilensis collected in the Pacific Sea, Los Molles (IV Región, Chile), during 
September 2007. A sample of this strain was deposited in the Laboratory of 
Marine Natural Products of the Universidad de Chile coded as 2P-22 and 
kept in agar slants with potato dextrose agar (PDA) as culture medium. The 
strain was seeded in Petri dishes with PDA culture medium in seawater and 
incubated for 7 days at 28ºC. Then, a solution of Tween 80 (0.05%) in sterile 
distilled water was used to obtain a spore suspension. This suspension was 
poured into an Erlenmeyer flask containing 150 mL of Czapeck medium (5g 
of yeast extract, 30g of sucrose, 2g of KNO3, 0.5g of KCl, 0.01g of FeSO4 
x7H2O, 0.5g of MgSO4 x7H2O, 1g of KH2PO4, 1L of seawater) and cultured 
at 27ºC with 230 rpm for 48 h to prepared a stock inoculum. The large-scale 
fermentation was performed in Erlenmayer flask (10 x 1L each) containing 200 
mL of Czapeck medium and 20 mL of inoculum. The cultures were incubated 
on an orbital shaker (230 rpm) at 27ºC for 25 days.
The mycelium was removed from the culture broth by filtration. Both the 
broth and the mycelium were studied. First, the broth (10 L) was extracted 
with EtOAc, (3× 1.5 L). The resulting organic extract was dried under reduced 
pressure to obtain a brown solid (0.5 g), which was fractionated by column 
chromatography on silica gel using stepwise gradient elution from 70% hexane 
in ethyl acetate, to 100% ethyl acetate, to 100% methanol. The volume eluted 
in each step was 0.5 L, and 10 fractions were obtained and evaporated to 
dryness. Moreover, the dried mycelium (12 g) was first extracted with CH2Cl2 
(3 × 1 L) to give 1 g of dichloromethane extract and then with CH3OH (3 × 1 L) 
to obtain 11 g of methanol extract. Purification of the resulting fractions of the 
organic culture broth allowed us to obtain the pure compounds 1-4 as follows: 
the methanol extract was fractionated on a Sephadex LH-20 column using a 
6:2:1 n-hexane/CH2Cl2/MeOH solvent system to obtain 20 fractions. Fraction 
10 (100 mg) was further separated using silica gel (200-300 mesh) CC with 
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a gradient solvent system from 50% petroleum ether/EtOAc to 100% EtOAc 
to yield 27 fractions (50 mL for each fraction). The fractions were monitored 
by TLC. Further purifications were made by chromatography on silica gel 
isolating compounds 1 and 2. From the purification by chromatography on 
silica gel using as mobile phase hexane/EtOAc (8:3), fractions 15 and 18 
contained compounds 3 and 4 respectively. Compounds 2 - 4 were identified 
by comparison of their spectroscopic properties with those reported 8-13.
Compound (1): 1H-NMR(δ, 400 MHz,): 7.59 (2H, d, J= 8.8 Hz, H-5’ 
and H-9’), 6.90 (2H, d, J= 8.8 Hz, H-6’ and H-8’), 6.58 (1H, brs, H-5),  6.55 
(1H, d, J= 8.3Hz, H-8), 6.52 (1H, dd, J= 2.0, 8.3 Hz, H-9), 4.94 (1H, t, J= 4.9 
Hz, H-11), 3.78 (3H, s, OCH3), 3.76 (1H, t, J=4.9 Hz, H-11), 3.53 (1H, d, 
J=14.7 Hz, H-3a), 3.45 (1H, d, J=14.7 Hz, H-3e), 2.88 (1H, dd, J= 4.6, 17.0 
Hz, H-10a), 2.62 (1H, dd, J= 5.1, 17.0 Hz, H-10e), 1.31 (3H, s, Me-13), 1.24 
(3H, s, Me 14). 13C-NMR: 169.7 (C-1), 85.9 (C-2), 38.7 (C-3), 128.0 (C-4), 
132.1 (C-5), 118.2 (C-6), 151.9 (C-7), 116.7 (C-8), 129.6 (C-9), 31.0 (C-10), 
69.6 (C-11), 77.2 (C-12), 24.6 ( C-13), 22.4 (C-14), 169.2 (C-1’), 137.4 (C-2’), 
124.7 (C-3’), 128.0 (C-4’), 129.5 (C-5’ and C-9’), 116.0 (C-6’ and C-8’), 156.6 
(C-7’). EIMS m/z (rel. int.): 458[M]+ (1), 440 (3),  422 (2), 405 (15), 391 (4), 
319 (5), 237 (7), 217 (12), 216 (63),  202 (8),  154 (6), 149 (10), 122 (9), 104 
(13), 99 (36),  94 (57), 93 (5);
Compound (1a): 1H-NMR (δ, 400 MHz): 7.72 (2H, d, J= 8.8 Hz, H-5’ and 
H-9’), 7.20 (2H, d, J= 8.8 Hz, H-6’ and H-8’), 6.62 (1H, dd, J= 1.5, 8.5 Hz, 
H-9),  6.58 (1H, d, J= 8.5 Hz, H-8), 6.48 (1H, brs, H-5),  4.94 (1H, t, J= 5.2 Hz, 
H-11), 3.78 (3H, OCH3), 3.56 (1H, d, J=14.8 Hz, H-3a), 3.45 (1H, d, J=14.8 
Hz, H-3e), 2.90 (1H, dd, J= 5.1, 17.3 Hz, H-10a), 2.60 (1H, dd, J= 5.3, 17.3 Hz, 
H-10e), 2.33 (3H, s, Me-18), 2.02 (3H, s, Me-16), 1.25 (6H, s, Me-13 and Me 
14). 13C-NMR: 170.6 (C-1), 86.0 (C-2), 38.5 (C-3), 126.6 (C-4), 131.7 (C-5), 
117.9 (C-6), 151.9 (C-7), 116.8 (C-8), 129.6 (C-9), 28.1 (C-10), 70.9 (C-11), 
75.1 (C-12), 24.8 (C-13), 22.6 (C-14), 169.6 (C-15), 21.1 (C-16), 168.7 (C-17), 
21.0 (C-18), 169.1 (C-1’), 138.8 (C-2’), 124.4 (C-3’), 127.2 (C-4’), 128.9 (C-5’ 
and C-9’), 122.2 (C-6’ and C-8’), 151.0 (C-7’); EIMS m/z (rel. int.): 542[M]+ 
(1), 525 (9), 524 (5), 465 (28), 405 (18), 412 (11), 352 (12), 313 (21), 261 (10), 
231 (28),  256 (30), 216 (10), 173 (35), 99 (12), 88(2);
Biological activity
Antibacterial assay:
The antibacterial activity was determined in solid media by the paper disc 
diffusion method14. The MIQ was measured as the minimal quantity that showed 
a transparent halo of growth inhibition. Five phytopathogen bacterial strains 
were used in the bioassay: Pseudomonas syringae pv syringae, Xanthomonas 
arboricola pv juglandis 833, Erwinia carotovora, Agrobacterium tumefaciens 
A348 (Gram-negative bacterias) and Clavibacter michiganensis 807 (Gram-
positive bacteria). Benzylpenicillin potassium salt (Sigma-Aldrich) and 
streptomycin sulfate (Calbiochem) were used as positive antibiotics.
Antitumor assay:
Antitumor activity of compounds was assessed with the potato disc 
method described by McLaughlin and Rogers in 199815. In brief, potato tubers 
were surface sterilized in 1% NaClO for 20 min. Potato discs (5 mm thick) 
were made with cork borer and placed on 2% agar plates (5 discs per plate). 
To each potato disc was applied 0.05 mL of a solution containing 2 mL of a 
broth culture of A. tumefaciens (48 h culture in Lauria-Bertani broth medium), 
1.5 mL of sterile water and 0.5 mL of the solution of the compound tested (8 
mg of compound in 2 mL of dimethyl sulfoxide, DMSO). Control discs were 
prepared with DMSO. A minimum of three Petri dishes (% discs/dish) (n= 15-
25) were used for each test compound and the control. After preparation, the 
Petri dishes were placed in an incubator at 27º C for 12-21 days. The crown 
galls on the potato tuber discs were observed by the naked eye. Numbers of 
tumors per disc were counted, and percent inhibition for each concentration 
was determined as % inhibition= 100- (average number of tumors of sample/ 
ditto for the control) x100. 
Functional (contraction/relaxation) studies in rat isolated thoracic aorta 
rings: 
Endothelium-denuded vascular rings were prepared from aortae of 
male Wistar rats weighing 210-270 g, essentially as described elsewhere16. 
Contraction studies were performed following the general procedure previously 
reported17. In the present study, however, isometric contractions were recorded 
by means of force-displacement transducers (Dynamometer UF1, Pioden 
Controls Ltd.,) connected to a MacLab® system (ADInstruments Pty Ltd,), 
controlled by a Power Macintosh 5500-225 computer. 
After an equilibration period of at least 1 h, isometric contractions 
induced by L-phenylephrine (1 µM) were obtained. When contraction of the 
tissue in response to this vasoconstrictor agent had stabilized (after about 20 
min), cumulatively increasing concentrations of the tested compounds (1-
200 µM) were added to the bath at 5-10 min intervals (the time needed to 
obtain steady-state relaxation). Control tissues were subjected to the same 
procedures simultaneously, but omitting the compounds and adding the vehicle 
(appropriate dilutions of DMSO). 
Contractile responses to phenylephrine are expressed as a percentage of 
the maximal contraction produced by this vasoconstrictor agent before the 
addition of the tested compounds. Sigmoidal concentration-response curves 
for the vasorelaxant effects of compounds were fitted using the program 
OriginTM 7.0 (Microcal Software, Inc., Northampton, USA), with estimation 
of IC50 values (i.e. concentrations inducing 50% relaxation) for phenylephrine-
induced contractions.
Significant differences between two means (p < 0.05 or p < 0.01) were 
determined by one-way analysis of variance (ANOVA) followed by the 
Dunnett’s post-hoc test. 
Appropriate dilutions of the above drugs were prepared every day 
immediately before use in deionized water from the following concentrated 
stock solutions kept at -20oC: the tested compounds (100 mM) in DMSO; 
L-phenylephrine (100 mM) in deionized water. In our experiments, neither 
deionized water nor appropriate dilutions of the vehicle used had significant 
pharmacological effects.
RESULTS AND DISCUSSION
Chromatographic separation of compounds extracted from the culture 
of 2P-22 strain, Aspergillus sp. led to the isolation of 4 compounds 1–4: 
one new, 1, and three known compounds, named butyrolactone I, 211, and 
the two sesterterpenoids terretonin A, 3 and terretonin B, 48,9. The structures 
of the known compounds were confirmed by comparing their spectroscopic 
properties with those reported8-13.
Compound 1 was obtained as colourless crystals. Its molecular formula 
was established as C24H26O9 (m/z 458.0). The 13C NMR and DEPT spectra of 1 
showed 24 carbon signals for two methyl, one methoxy, two methylene, eight 
methines and 11 quaternary carbon atoms including two carbonyl carbons and 
a sp3 carbon bearing a hydroxyl group. The 1H NMR spectra of 1 displayed 
signals for a 1,4-disubstituted phenolic moiety at δ 7.59 (2H, d, J= 8.8 Hz) and 
6.90 (2H, d, J= 8.8 Hz), three aromatic proton signals of a 1,2,4-trisubstituted 
phenol (δ 6.58, 6.55 and 6.52 ppm ),  a signal at δ 3.78 (3H, s, OMe), a triplet 
at δ 3.76 (J= 4.9 Hz) corresponding to a hydrogen geminal to a hydroxyl group, 
a pair of doublets at δ 3.53 and 3.45 (1H each, d, J=14.7 Hz) corresponding to 
the methylene connecting  the butyrolactone with the trisubstituted aromatic 
ring, two double doublets  at δ 2.88 (1H, dd, J = 4.7, 17.0 Hz) and 2.62 (1H, 
dd, J=5.03, 17.0 Hz), and two methyl groups at 1.31 and 1.24 ppm ( See 
Experimental). The 1H–NMR data of compound 1 closely resembled those of 
butyrolactone I, 2 (Figure 1), with the only difference being the chemical shift 
of the prenyl residue, ie. the absence of a double bond in 2 and the appearance 
of a triplet at δ 3.76 in 1 corresponding to a hydrogen geminal to a  hydroxyl 
group.
In order to verify this structure, compound 1 was treated with acetic 
anhydride in pyridine affording compound 1a. The comparison of the 1H–NMR 
spectra of compounds 1 and 1a showed only minor differences. The signal at δ 
3.76 was shifted to 4.94 ppm in 1a, which suggested that the hydroxyl group at 
C-11 was acetylated, and the protons of 1,4-disubstituted phenol where shifted 
from δ 7.59 and 6.90 ppm in 1 to 7.72 and 7.20 ppm, indicating the acetylation 
of the 1,4 disubstituted phenol.
The structure of 1a (Figure 1) was determined based on the 1H–13C long-
range correlations of the phenyl proton at δ 7.72 (H-5’ and H-9’; δC 128.9) 
with the carbons at δ 122.2 (C-6’ and C-8’) and 151.0 ppm (C-7’), and the 
phenyl protons at  δ 7.20 (H-6’ and H-8’) with the carbons at δ 128.9 (C-5’ 
and C-9’) and 151.0 (C-7’); the correlations between the multiplet at δ 6.62 
(corresponding to the phenyl protons H-8, δC 116.8 and H-9, δC 129.6) with 
carbons at δ  38.5 (C-3), 151.9 (C-7) and 131.7 (C-5); the 1H–13C long-range 
correlations of the methyl protons at δ 1.25 (H-13 and H-14) with the carbons 
at δ  70.9 (C-11) and 75.1 (C-12). The protons at δ 3.56 and 3.44 (H-3) showed 
long-range correlations with the carbons at δ 170.6 (C-1), 86.0 (C-2),  126.6 
(C-4), 131.7 (C-5) and 129.6 (C-9) indicating that this carbon is the linkage 
between the butyrolactone and the trisubstituted aromatic ring. The pair of 
double doublets at δ 2.90 and 2.60 showed 1H–13C long-range correlations with 
δ 70.9 (C-11), 75.0 (C-12), 117.9 (C-6), 131.7 (C-5) and 151.9 (C-7) indicating 
that the chain was linked to C-6.
The assignments of the quaternary carbons were determined based on the 
comparison with butyrolactone I 2.11 Thus, the structure of compound 1 was 
elucidated as  butyrolactone-VI. (Figure 1) 
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Biological activity
The result of the antibacterial activity assay shows that 1 and 2 were only 
active against Clavibacter michiganensis. The MIQ value of butyrolactone VI 
(1) was   50 μg. The crown gall tumor bioassay used to test the compounds 
for antitumor activity was performed essentially according to McLaughlin & 
Rogers15. It has been demonstrated that the compounds which inhibit these 
plant tumors have a high predictability of showing activity against the P288 
(3PS) leukaemia in mice18 and, in general, of disrupting the cell cycle (mitosis, 
S phase, etc.) regardless of their mode of action19. Compounds 1 and 2 showed 
a similar and significant inhibition of the growth of crown gall tumors on potato 
discs. The values were: butyrolactone I 2 (84, 46%) and butyrolactone VI 1 (71, 
64%), which suggests in vivo antitumor activity for both compounds.
Butyrolactone I 2 was acetylated as usual (Py/acetic anhydride) yielding 
compound 2a. The potential vasorelaxant effects of compounds 2 and 2a 
were evaluated on endothelium-denuded rat aortic rings precontracted with 
L-phenylephrine.16,17L-phenylephrine caused slow and sustained contraction of 
the rat isolated aortic rings without endothelium. The maximal tension (mg) 
reached was 2053.9 ± 89 (n=5). These contractile effects were maintained 
without significant tension changes in control rings for at least 90 min. 
DMSO had no significant effects on  phenylephrine-induced contractions in 
endothelium-denudes rat aortic rings (n=5, p>0.05). The cumulative addition 
of the tested compounds (20-200 µM) concentration-dependently relaxed 
the contractions induced by L-phenylephrine (Figure 2). The butyrolactone 
I acetate was slightly less efficient than butyrolactone I in relaxing these 
contractions. However, the corresponding IC50 values of both compounds did 
not present significant differences (Table 1).
potential vasorelaxant effects obtaining good responses suggesting that further 
studies to assess the potential of this type of structure are merited.
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Figure 2. (a). Cumulative concentration-relaxation curves for the tested 
compounds (20-200 µM) in endothelium-denuded rat thoracic aortic rings 
pre-contracted with phenylephrine (1 µM). (b) Each point represents the mean 
value ± s.e.m. (indicated by vertical lines) from 5 experiments. (c)  Level of 
statistical significance: *p <0.01 o **p <0.05 with respect to the maximal ten-
sion (100%), as determined by ANOVA/Dunnett’s.
Table 1..- IC50 values (µM) for the vasorelaxation induced by the tested 
compounds in endothelium-denuded rat aortic rings pre-contracted with 
L-phenylephrine.
Compound IC50 (µM)
2 91.6 ± 7.1 (n=6)
2a 121.7 ± 9.8 (n=5)
Each value represents the mean ± s.e.m from experiments shown in brack-
ets.
CONCLUSIONS
In summary, a new cytotoxic compound, butyrolactone VI, 1, has been 
isolated from a strain of Aspergillus sp, isolated from a Chilean sponge Cliona 
chilensis. Its structure resembles that of other butyrolactones, previously 
characterized from marine strain of Aspergillus terreus and Aspergillus sp.10-13. 
These compounds were tested for antibacterial and antitumor assays and for 
